about
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcomeDomain-wide regulation of gene expression in the human genomeIntratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid stateGenome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionCASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.Refined physical mapping and genomic structure of the EXTL1 geneThe MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell typeLysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapyTargeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsThe human transcriptome map: clustering of highly expressed genes in chromosomal domainsDiscovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysis.Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingLocalization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis typeIntegrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationEfficient double fragmentation ChIP-seq provides nucleotide resolution protein-DNA binding profiles.Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patientsNF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genesDesign of a multi-signature ensemble classifier predicting neuroblastoma patients' outcomeGenome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markersIdentification of BIRC6 as a novel intervention target for neuroblastoma therapy.Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 statusThe role of the MEIS homeobox genes in neuroblastoma.Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.The three-dimensional structure of human interphase chromosomes is related to the transcriptome map.DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells.The role of histone demethylase KDM4B in Myc signaling in neuroblastoma
P50
Q24313063-274A06E0-CE07-471B-AD02-E0F7E568AF0EQ24676961-A0939D79-250A-4B5C-8796-567ADFFDEDE2Q27334127-63799810-0223-4032-A8E6-9B10F7B662CDQ27852966-5769FD56-1C83-4F92-8A41-BC0B8417604FQ27853102-D8C21672-B5CD-4A5D-B333-46534391CBC6Q28138787-87FBD0B8-1E3E-4412-AB10-0788A677AD9AQ28143160-966ACD7F-E4AD-4750-8227-B2C8DF0532F8Q28188252-A93D318D-78B9-45BD-AF12-C74DC8D02D82Q28235397-495E67CA-AAED-417B-B089-305653A8DAC1Q28554501-0364CB70-E960-4BF3-828C-70F90C4A8C07Q29622859-87140AF5-B754-4C30-A1CE-90D44189BD60Q30571372-EB4E747F-5C6D-4EBF-8426-9C37E6B5AAB0Q30858189-464D05C0-DA7C-481A-BC43-12A0860B5041Q31106248-24C8C457-9AEA-4BA0-8111-1F863A77EDA5Q33366431-28F3BF59-7323-4BC9-B3D2-58772257AF10Q33450146-BB6A05AB-34CD-4972-B997-5C8D93F2B4D3Q33559546-F11DBD8C-5433-4458-876B-BF6B2A1C808CQ33761692-B7171626-14A6-4E3C-93C8-46F4326314A4Q33770079-72E1B282-D825-4BE1-BABD-0B6C5F1ABD68Q33891903-05D953C1-2AA4-4344-96E4-314438736CC2Q34031980-B972A798-6773-4468-A012-7437B41BE668Q34053468-3F215969-B8AE-479A-8CBC-F82998433C2BQ34092388-1FB33578-1A02-4AC2-8CDA-F626057FA8F0Q34210060-921154D3-45CC-4D4E-A830-181B8A611A3BQ34221918-746A11C6-E35C-4270-8748-2F927A61F652Q34247959-F80A8DB8-213A-4AB4-9A47-8082D3524619Q34248736-2601D6D5-E096-4D9E-9194-FE5846772E83Q34257086-05193A52-9B94-46BA-A535-8E5703AA89EEQ34280882-295C983E-7404-4F9E-93A8-6FBDF57C3276Q34334471-8B7E6DEC-CBF1-4F3C-BD0C-5E895ED267DCQ34354839-B34AB1B9-17B8-4B7E-A607-469E69F85D8DQ34362028-161CD95C-B76B-4874-9C23-6449F8B09B3EQ34489061-991360C8-AFF4-4A1F-AB2B-FB6C0A3EFD88Q34515911-ED0D97DE-EBD5-4CF3-BD72-D25B6AEAFC67Q34979644-89536FE6-DA9C-4640-BB10-8B11918B7382Q35184946-E855EBFE-4246-430B-A152-DED26B0D1405Q35617266-BAA20523-59F0-4E30-88A2-6B6E7FE123A4Q35857089-E4F35819-CD50-44FD-9CBE-F808B3B0EAE6Q35881648-93D60E59-80D1-4015-B27A-650D15102BA1Q36014044-F93954FA-83B7-4026-BF5F-6972CA65A1A1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rogier Versteeg
@ast
Rogier Versteeg
@en
Rogier Versteeg
@es
Rogier Versteeg
@nl
Rogier Versteeg
@sl
type
label
Rogier Versteeg
@ast
Rogier Versteeg
@en
Rogier Versteeg
@es
Rogier Versteeg
@nl
Rogier Versteeg
@sl
prefLabel
Rogier Versteeg
@ast
Rogier Versteeg
@en
Rogier Versteeg
@es
Rogier Versteeg
@nl
Rogier Versteeg
@sl
P106
P2456
P31
P496
0000-0001-7172-0388
P569
1955-01-01T00:00:00Z